Bengaluru: Union Minister for Chemicals and Fertilizers D.V. Sadananda Gowda (DVS) on Thursday said that a proposal to suspend protection under the Patents Act for Covaxin, the home-made COVID-19 vaccine by Bharat Biotech, is under 'serious consideration.'
Speaking to newsmen here, he said a Committee had been set up to look at the patent waiver for Covaxin after the United States recently backed a move to suspend Intellectual Property (IP) Rights for Covid-19 vaccines and other key medicines.






